Transgene Biotek: Trading Window Closed

Transgene Biotek Ltd has announced the closure of its trading window for Directors, Key Managerial Personnel (KMPs), Designated Employees, and Connected Persons. The closure is effective from Thursday, October 1, 2026, and will remain in effect until 48 hours after the declaration of the company's un-audited financial results for the second quarter ending September 30, 2026. This action is in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015. The date for the Board Meeting to consider these results will be intimated subsequently.